RecoveryFDA Approved

Pentosan Polysulfate (Elmiron)

Oral

Overview

A semi-synthetic sulfated polysaccharide derived from beechwood hemicellulose with structural similarities to glycosaminoglycans. Pentosan polysulfate replenishes the defective glycosaminoglycan layer of the bladder urothelium in interstitial cystitis, reducing urothelial permeability to irritants.

Mechanism of Action

It also exhibits anti-inflammatory, anticoagulant, and fibrinolytic properties through inhibition of complement activation and mast cell histamine release..

Research Summary & Key Findings

FDA-approved for interstitial cystitis/bladder pain syndrome (1996). Clinical trials demonstrated significant symptom improvement in 30-40% of patients. Post-marketing surveillance identified risk of pigmentary maculopathy with long-term use, prompting updated labeling (Hanif et al., Ophthalmology, 2019).

Clinical Status

FDA Approved

Pentosan Polysulfate (Elmiron) has received FDA approval and is available for clinical use under appropriate medical supervision. Consult a qualified healthcare provider for prescribing information.

Administration Routes

Oral

Related Peptides in Recovery

Find a Provider

Find a verified provider who offers Pentosan Polysulfate (Elmiron) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Pentosan Polysulfate (Elmiron).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.